These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 5984181)

  • 1. Acquired immunity to Ehrlich ascites tumor in mice after treatment with fresh or sonized tumor cells at various ages.
    Yasuhira K
    Acta Tuberc Jpn; 1966 Dec; 16(2):78-84. PubMed ID: 5984181
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on anti-tumor immunity. I. Homologous immunity against Ehrlich ascites tumor (acquired type of immunity against tumor).
    Soeda M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Mar; 26(12):1598-608. PubMed ID: 5232509
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth of subcutaneous grafts of some clones of Ehrlich ascites tumor in mice of different strains.
    Bregula U; Slowikowska G; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):711-6. PubMed ID: 5957992
    [No Abstract]   [Full Text] [Related]  

  • 4. Dynamics of growth and regression of Ehrlich ascites carcinoma transplanted intraperitoneally in rats.
    Janik P; Dabrowski M; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):717-23. PubMed ID: 5957993
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the survival of skin grafts from normal mice and mice with Ehrlich ascites tumor.
    Hur NB; Biran S; Robinson E
    Transplantation; 1966 Mar; 4(2):205-6. PubMed ID: 5326924
    [No Abstract]   [Full Text] [Related]  

  • 6. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.
    Carry PJ; Prescott DM; Ogilvie GK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2139-40. PubMed ID: 445411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing skin graft survival from donors with Ehrlich ascites tumor.
    Biran S; Ben-Hur N; Robinson E
    Oncology; 1970; 24(5):344-8. PubMed ID: 4922595
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigations on mononuclear cells of animals sensitized against homologous normal tissue transplants and tumor transplants.
    Warnatz H
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):748-52. PubMed ID: 5334579
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of Ehrlich tumor on allogenic skin transplantation in mice].
    Belokhvostov AS
    Vopr Onkol; 1970; 16(11):61-5. PubMed ID: 4929049
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimentally acquired resistance to tumor transplantation and the rejection of homologous skin transplantation in mice].
    Enoki Y
    Igaku To Seibutsugaku; 1967 Mar; 74(3):185-6. PubMed ID: 4861830
    [No Abstract]   [Full Text] [Related]  

  • 12. Restoration of allograft immunity in tumor-bearing animals by "immune" RNA.
    Rigby PG
    J Lab Clin Med; 1968 May; 71(5):775-83. PubMed ID: 4869636
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance and susceptibility to tumours. VI. Reaction of labelled lymphoid cells transferred into the site of previously implanted carcinoma.
    Dvorák R; Lindner J
    Neoplasma; 1971; 18(1):63-86. PubMed ID: 5575435
    [No Abstract]   [Full Text] [Related]  

  • 14. A study on transplantation immunity of Ehrlich ascites tumor and methylcholanthrene-induced tumor in mice, with special reference to local immunity of lymph nodes draining the site of sensitization.
    Kitano M; Okada Y
    Bull Chest Dis Res Inst Kyoto Univ; 1968 Mar; 1(1):1-17. PubMed ID: 5678190
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A; Hristescu S; Mazilu E
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The theta antigenicity of lymphoid organs of mice bearing the Ehrlich ascites tumor.
    Loring M; Schlesinger M
    Cancer Res; 1970 Aug; 30(8):2204-7. PubMed ID: 5466693
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the behavior of skin autografts following their in vitro treatment with cancer cells.
    Biran S; Ben-Hur N; Robinson E
    Isr J Med Sci; 1969; 5(5):1077-8. PubMed ID: 4905243
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of epsilon-aminocaproic acid on the growth of tumor cells in immunized mice].
    Bonmassar E; Celi ML; Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(1):187-94. PubMed ID: 5745501
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nonspecific suppressive effect of Ehrlich tumor ascitic fluid on transplantation immunity].
    Belokhvostov AS; Zelenkova NK
    Biull Eksp Biol Med; 1978 Oct; 86(10):474-6. PubMed ID: 361103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of purine-protein conjugates on the Ehrlich ascites tumor in mice.
    Lachman C; Cohen S
    Cancer Res; 1970 Feb; 30(2):439-46. PubMed ID: 5441091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.